1. Introduction {#s0005}
===============

Veterinary drugs are used inevitably in animal breeding for therapeutic or disease-preventive reasons in parallel with promoting growth of livestock [@bib1]. Such compounds have become an integral part of the livestock-producing industry. However, when withdrawal periods are not obeyed, unsafe antibiotic residues, or their metabolites, may be present in edible products such as milk, eggs and meat. It is reported that the traces of antibiotics in food can be dangerous for consumers because of their direct toxicity and the emergence of antibiotic-resistant bacteria [@bib1], [@bib2]. Currently, the fluoroquinolones (FQs), sulfonamides (SAs) and tetracyclines (TCs) are types of broad spectrum antibiotics, which are used commonly in human and animal medicine. Some of FQs have many effects, such as carcinogenicity, mutation and so on, and several of them may cause photosensitization and allergic reaction, etc. [@bib3], [@bib4], [@bib5]. SAs can cause side effects that make micturition and hematopoietic disorder [@bib6], and TCs can damage liver and kidney and influence the growth of skeleton and other side effects [@bib7]. And furthermore, all of the above-mentioned veterinary drugs can enhance the drug-resistance of bacteria [@bib2]. Human health will be threatened by excess residues of FQs, SAs and TCs in the animal products.

To prevent consumers from suffering with the possible health problems, the authorities have regulated the use of veterinary drugs by setting the maximum residue limits (MRLs) or by prohibiting the use of many substances. According to the US Food and Drug Administration (FDA), none of the (FQs are allowed to be present in the food supply. China and the European Union (EU) have established MRLs for FQs in foods of animal origin at 10--1900 μg/kg [@bib8], [@bib9]. MRLs in animal food products, established by EU, Japan, America and China, equals 100 μg/kg for SAs and tetracycline (TC) [@bib10].

This study focuses on these groups of antibiotics in developing a sensitive method that can be utilized to investigate their fate in complicated animal tissues matrix. Multiresidue methods, which enhance the efficiency of analysis, are available for determination of FQs, SAs and TCs in wastewater [@bib11], [@bib12]. Multiresidue methods, which will simultaneously determine more than one class of veterinary drugs in any matrix, are still limited and are largely confined to liquid chromatography--mass spectrometry (LC--MS) methods [@bib13], [@bib14]. LC--MS methods are capable of identifying individual antibiotics within a class but involve relatively expensive and complex instrumentation, which may not always be available for routine monitoring. LC--MS methods can be valuable when confirmation is required, but are not always necessary for quantitation. LC with fluorescence detection (FLD) has been reported to have a low detection limit. However, the technique certainly requires derivatization to improve the fluorescence properties for detection [@bib15]. The use of diode array detector (DAD) as a detector for high performance liquid chromatographic (HPLC) has proved to be a powerful tool in the determination and identification of compounds as it makes possible the on-line acquisition of their UV spectra. In addition, most of the above mentioned methods are for one class of antibiotics only [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21]. A challenge is presented in the simultaneous extraction and analysis of multiple classes of compounds.

The aim of this study is to develop a method for simultaneous determination of selected antibiotics drugs: FQs \[Enoxacin (ENO) and lomefloxacin (LOM)\], SAs \[sulfanilamide (SN) and sulfamethoxazole (SMZ)\] and TCs \[tetracycline (TC)\] ([Fig. 1](#f0005){ref-type="fig"}) in high complex porcine tissues matrix. The method involves sample pre-treatment with matrix solid-phase dispersion (MSPD) and analytical determination with high performance liquid chromatography (HPLC) coupled with diode array detector (DAD).Figure 1Chemical structures of the selected drugs in this study.

2. Experimental {#s0010}
===============

2.1. Materials {#s0015}
--------------

Enoxacin (ENO, 91.1%), lomefloxacin (LOM, 90.0%), sulfanilamide (SN), sulfamethoxazole (SMZ) and tetracycline (TC) were obtained from National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). HPLC-grade methanol (MeOH) and acetonitrile (ACN) were obtained from Burdick & Jackson (Muskegon, MI, USA) and HPLC-grade acetic acid (HAc) from Kermel Chemical Reagents Development Centre (Tianjin, China). C~18~ (50 μm) was obtained from Baseline Chrom. Tech. (Tianjin, China). Triple distilled water (18.3 MΩ cm resistivity) was prepared by a Molelement water purification system (Molecular, Shanghai, China). All solutions prepared for HPLC were filtered through a 0.45 μm filter before used. Porcine tissues, which were purchased from a local food market, were served as samples and were deep-frozen prior to the analysis.

2.2. Standard solutions {#s0020}
-----------------------

Individual standard stock solutions such as ENO, LOM, SN, SMZ and TC with concentration of 500 μg/mL were diluted with 10% methanol and stored protected from light at 4 °C. A fortification mixture of ENO, LOM, SN, SMZ and TC (10 μg/mL) in 10% methanol was prepared from these stock solutions on the day of the analysis. When the lower level of fortification solution was required, additional dilution with 10% methanol was conducted. To ensure an accurate analysis, the preparation of fortification solutions was performed on the day of the analysis.

2.3. The procedure of matrix solid-phase dispersion (MSPD) {#s0025}
----------------------------------------------------------

The porcine tissue samples were cut into pieces and blended. 0.50 g sample was placed in a glass mortar with the external diameter of 90 mm, and the standard mixture solution was added. The sample was placed in the dark chamber sitting for 20 min. Two grams C~18~, 0.05 g EDTA--Na~2~ and 0.05 g oxalic acid were then added in the mortar and gently ground with the sample with a pestle to obtain a homogeneous material. One gram anhydrous sodium sulfate, 0.25 g C~18~, the C~18~/tissue matrix blend and 0.5 g anhydrous sodium sulfate were introduced in order into a 10 mL syringe barrel pre-plugged with a filter disk, and the barrel was then placed on a vacuum manifold. Flow was controlled at 1.0 mL/min. The C~18~/tissue matrix blend was washed with 6 mL *n*-hexane to remove lipids, and eluted with 8 mL ACN--dichloromethane (1:1, v/v). The eluate was evaporated to dryness with a gentle stream of air, and then the residue was dissolved in 1 mL 10% methanol. The final solution was filtered through a 0.45 μm disposable syringe filter unit and 20 μL volume of the filtrate was injected into the HPLC system.

2.4. HPLC--DAD analysis {#s0030}
-----------------------

The LC analyses were accomplished with an LC-10Avp (Shimadzu, Japan) HPLC system consisting of an LC-10ATvp secondary pump system, DGU-12A on-line degasser, CTO-10ASvp thermostatted column compartment and SPD-M10Avp diode array detector. CLASS-VP software controlled the LC components and processed ultraviolet data and a Kromasil C~18~ chromatography column (150 mm×4.6 mm, 5 μm) was used.

Solvent A (0.1% HAc) and solvent B (MeOH) were combined in a gradient as follows: 15--25% B (3 min), 25--45% B (3 min), 45% B (5 min), 45--15% B (4 min). The flow rate was 1.0 mL/min, and the column heater was set at 25 °C. The investigated drugs were eluted for 15 min and a 15 min post time allowed re-equilibration of the column. ENO, LOM, SN, SMZ and TC were monitored at absorbance wave-length of 280 nm ([Fig. 2](#f0010){ref-type="fig"}). The retention time for the drugs is shown in [Table 1](#t0005){ref-type="table"}.Figure 2HPLC--DAD chromatograms of a 5 μg/mL standard solution, *λ*=280 nm. 1, SN; 2, ENO; 3, LOM; 4, TC; 5, SMZ.Table 1The maximum UV-detection wavelengths and retention time of the five drugs.Drugs*λ* (nm)Typical retention time (min)SN2592.69ENO2697.21LOM2888.08TC2648.93SMZ27010.09

3. Results and discussion {#s0035}
=========================

3.1. The procedure for MSPD {#s0040}
---------------------------

The traditional extraction--purification of the antibiotics involves numerous and varying analytical steps, which are labor intensive and time consuming. In this study the matrix solid-phase dispersion extraction (MSPD) first developed by Staren Barker et al. [@bib22] was chosen, for its easy use, possible automation, and multiresidue potential. MSPD involves homogenizing and dispersing of a small amount of matrix with adsorbent (usually C~18~ or C~8~), washing with a small amount of solvent and elution to extract a wide range of compounds. The MSPD mechanism appears to encompass sample homogenization, cellular disruption, extraction, fractionation and purification in one single process.

### 3.1.1. Optimization of the rinsing and eluting conditions {#s0045}

Based on 2.0 g C~18~ and 0.50 g porcine tissue, the rinsing and eluting conditions were investigated (the spiking level was 0.5 μg/g). *n*-Hexane, the different mixture of ACN and CH~2~Cl~2~, and the mixture of MeOH and CH~2~Cl~2~ were used to optimize the rinsing and eluting conditions. The average recoveries of the drugs in different rinsing and eluting conditions are shown in [Table 2](#t0010){ref-type="table"}.Table 2Recoveries (%) of the drugs in different ringing and eluting conditions.Rinsing and eluting solventsSNENOLOMTCSMZ6 mL C~6~H~14~n.d.n.d.n.d.n.d.n.d.8 mL CH~3~CN/CH~2~Cl~2~ (v/v=1:3)93.580.285.178.690.78 mL CH~3~CN/CH~2~Cl~2~ (v/v=1:1)94.393.195.379.686.48 mL CH~3~CN/CH~2~Cl~2~ (v/v=3:1)68.690.294.380.862.08 mL CH~3~OH/CH~2~Cl~2~ (v/v=1:1)84.375.377.575.080.9[^1]

The data in [Table 2](#t0010){ref-type="table"} indicates that 6 mL *n*-hexane cannot elute the drugs. When eluting the drugs with 8 mL ACN/CH~2~Cl~2~ (1:3, v/v), the recoveries of two SAs were \>90%. When eluting the drugs with 8 mL ACN/CH~2~Cl~2~ (3:1, v/v), the recoveries of two FQs were \>90%. However, the best recoveries of all the drugs were obtained with 8 mL ACN/CH~2~Cl~2~ (1:1, v/v). Therefore, the proper rinsing and eluting solvents were 6 mL *n*-hexane and 8 mL ACN/CH~2~Cl~2~ (1:1, v/v), respectively. Based on the above procedures, the rinsing and eluting conditions for porcine tissue were tested, and similar results were obtained. Under the optimum conditions, the recoveries of the drugs were all above 80%. The results demonstrate that the MSPD-based method can reduce analysis time, solvent waste, and cost without affecting the quality of residue detection and measurement.

### 3.1.2. Optimization of the eluting solvent volume {#s0050}

The effect of the eluting solvent volume was studied by collecting each drug in every 0.50 g porcine tissue during eluting with a sample fortified at 0.5 μg/g. The cumulative recoveries on eluting with 10 mL of ACN are shown in [Fig. 3](#f0015){ref-type="fig"}. The recovery for each drug increased rapidly to 70% after elution with 4 mL of eluent, followed by a slow increase in the eluent volume and finally reaching an equilibrium value with 8 mL of eluent. The eluent volume used in the subsequent studies was accordingly set at 8 mL.Figure 3Cumulative recoveries of the five drugs in porcine tissue at 0.5 μg/g as a function of eluent volume. ![](fx1.gif)=SN; ![](fx2.gif)=ENO; ![](fx3.gif)=LOM; ![](fx4.gif)=TC; =SMZ.

3.2. HPLC--DAD {#s0055}
--------------

### 3.2.1. HPLC conditions {#s0060}

The isolation of FQs, SAs and TCs, and their separation from matrices are complicated, since their groups have a propensity to form chelate complexes with metal ions and sample matrix proteins, and interact strongly with silanol groups of siliceous sorbents. In this paper, EDTA--Na~2~ and oxalic acid were added in the MSPD-process to chelate with metal ions. Improved resolution of these different components was achieved by manipulating the solvent and additive composition (HAc, ACN, MeOH were used), the volume proportion of the solvents in the mobile phase and the concentration of HAc. MeOH (B) and 0.1% HAc (A) were selected. Further improvement in separation was obtained by mobile phase gradient. The gradient condition is as follows: 15--25% B (3 min), 25--45% B (3 min), 45% B (5 min), 45--15% B (4 min). Experimental conditions selected enable separation in 15 min.

### 3.2.2. Identification {#s0065}

The HPLC--DAD method chosen allows the separation of the drugs and identification of them by their retention time and their spectra (see [Table 1](#t0005){ref-type="table"} and Fig. 2). With a photodiode array detector, the absorption spectra of ENO, LOM, SN, SMZ and TC standards in the mobile phase were measured for the selection of the HPLC monitoring wavelength. The measurement was conducted at 280 nm, which gave an average maximum absorbance for all of the drugs.

3.3. Method validation {#s0070}
----------------------

### 3.3.1. Linearity {#s0075}

Eight point calibration curves were prepared for each analysis day. Quantitation utilized the UV peak area for each drug. The calibration curves were found to be linear over the range of 0.001--10 μg/mL studied (0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1, 5, 10 μg/mL levels were used). The linear equations, correlation coefficients and linear range of the drugs are presented in [Table 3](#t0015){ref-type="table"}. The results indicate that the correlation coefficient is equal to 0.9987--0.9997.Table 3Linear equations, correlation coefficients and linear range of the five drugs.CompoundRegression equationCorrelation coefficient (*r*)Linear range (μg/mL)SN*y*=4.4×10^4^*x*+1.8×10^3^0.99970.005--10ENO*y*=3.8×10^4^*x*−9.7×10^2^0.99970.005--10LOM*y*=7.2×10^4^*x*+1.7×10^4^0.99920.005--10TC*y*=2.0×10^4^*x*−7.5×10^2^0.99870.01--10SMZ*y*=7.5×10^4^*x*+2.4×10^3^0.99970.001--10[^2]

### 3.3.2. Intra-day and inter-day repeatability {#s0080}

Analysis of the calibration standards was applied in determining the intra-day (three repetitions of each concentration) and inter-day repeatability (three repetitions of each concentration, three days). The results (for three levels) are shown in [Table 4](#t0020){ref-type="table"}. The intra-day RSDs were lower than 9.3% and lower than 10.2% for inter-day assays. These results indicate that the method developed had acceptable precision.Table 4Intra-day and inter-day repeatability.AnalytesAmount injected (ng)Intra-day repeatabilityInter-day repeatabilityRSD (*n*=3) (%)RSD (*n*=9) (%)SN1.03.64.20.54.05.70.14.86.0  ENO1.01.52.30.52.83.10.13.54.0  LOM1.04.64.80.54.24.90.15.45.9  TC1.02.12.70.55.25.80.19.310.2  SMZ1.02.02.60.53.35.21.03.95.5

### 3.3.3. Accuracy {#s0085}

Accuracy of the method was tested by fortification of porcine samples at three known levels of 0.1, 0.5 and 1.0 μg/g, pre-processing, analysis and determination of the recovery for each drug, respectively. [Fig. 4](#f0020){ref-type="fig"} shows chromatograms of a representative blank and spiked porcine tissue at 0.1 mg/kg level and [Table 5](#t0025){ref-type="table"} summarizes the recoveries and the RSD obtained for each analyte. The results indicate that the average recoveries range from 80.6% to 103.1% and RSD of the peak areas change from 0.3% to 6.1%.Figure 4Chromatograms of: (a) extracted sample from spiked porcine tissues with 0.1 mg/kg and (b) blank extract, *λ*=280 nm. 1, SN; 2, ENO; 3, LOM; 4, TC; 5, SMZ.Table 5Average recoveries, RSD and LOQ of the drugs at three levels of spiking (*n*=5).DrugsAdded (mg/kg)Average recovery (%)RSD (%)LOD (μg/kg)LOQ (μg/kg)SN1.099.23.07240.593.11.00.188.33.6  ENO1.087.12.95170.587.53.50.187.01.1  LOM1.097.42.74140.597.51.30.189.04.0  TC1.086.41.610340.580.61.40.184.70.3  SMZ1.098.53.3270.586.46.10.182.33.0

The limit of detection (LOD) defined as a response 3 times the average height of the blank baseline noise was in the range 2--10 μg/kg and the limit of quantification (LOQ) defined as a response 10 times the average height of the blank baseline noise was 7--34 μg/kg, for porcine tissue samples, with 0.50 g in the MSPD method.

4. Conclusions {#s0090}
==============

The results show that the developed method in this study is robust and sensitive for simultaneous detection and quantification of two FQs, two SAs and one TC antibiotics in animal tissues matrix. The proposed MSPD methodology is relatively simpler, more efficient and economical compared with SPE, and is suitable for multiresidue analysis of the studied drugs in porcine tissues. With MSPD, cleanup steps or the addition of chemical agents to further separate the drugs from interfering substances before HPLC analysis of extract are not necessary. Moreover, it reduces the sample sizes and requires less solvent and reagent for efficient isolation of the compounds of interest. The procedure can be treated as a screening method, which enables detection of ENO, LOM, SN, SMZ and TC in animal-product tissues at the MRLs level and estimation of their amounts.

The improvement of sensitivity and accuracy on fully quantitative grounds, and the efficient simultaneous analysis of a wide range of veterinary drug residues in animal food products will be addressed in our future investigations.
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[^1]: n.d.: not detected; the relative standard deviations (RSDs) were between 2.5% and 9.6% (*n*=5).

[^2]: *y*: peak area; *x*: concentration (μg/mL).
